The Moscow-based company, “Vetbiohim,” has attained certification for its veterinary drug production site in adherence to the GMP standard of the Republic of Turkey. The international certificate guarantees the quality of the product and its compliance with international requirements.
“Vetbiokhim” built a plant on the territory of the SEZ in 2022, 1.6 billion rubles were invested in the project. The company has successfully initiated the manufacturing of 36 vaccines meant for both domestic and agricultural animals. Additionally, four serum and immunoglobulin preparations, along with 56 types of test systems have also been developed to assist in diagnosing various diseases.
Because of the GMP certificate issued by the Republic of Turkey, the Russian exporter now has the authorization to distribute its pharmaceutical products not only to the Turkish market, but also to the global market.
